期刊文献+

过氧化物酶体增殖物激活受体γ2基因Pro12Ala多态性与北京市汉族高血糖人群的胰岛素分泌相关 被引量:4

The PPARγ2 gene Pro12Ala polymorphism is associated with insulin secretion of hyperglycemia Han population in Beijing
原文传递
导出
摘要 目的研究过氧化物酶体增殖物激活受体(PPAR)γ2基因Pro12Ala多态性与北京市汉族人群肥胖、2型糖尿病的发生及胰岛素分泌的关系。方法使用口服75克葡萄糖耐量试验(OGTT)对北京市东城区非已知糖尿病汉族人群进行糖耐量检测,对其中的490例高血糖者(包括糖尿病及糖调节受损者)及585例糖耐量正常者进行病例对照研究。使用聚合酶链式反应-限制性内切酶片段长度多态性(PCR-RFLP)方法,对PPARγ2基因Pro12Ala多态性进行基因分型。结果病例组与对照组间PPARγ2基因Pro12Ala多态性频率分布无显著差别。病例组中,携带Ala12等位基因者的腰围明显增大(P=0.028);并且携带Ala12等位基因者的OGTT服糖后0.5,1及2小时的胰岛素水平明显低于对照组(P=0.026;P=0.040;P=0.038)。结论本研究提示在已有糖代谢紊乱的人群中,Ala12等位基因可能是加重其腹型肥胖并抑制其葡萄糖刺激后胰岛素分泌的一个因素。 Objective The purpose of this study is to investigate the association of Pro12Ala polymorphism at the PPARγ2 gene in Han population of Beijing with type 2 diabetes and islet function. Methotis Using oral 75g glucose tolerance test (OGTT) method,we systematically screen glucose tolerance in Han population in Dong-cheng district of Beijing. A case-control study comprised 490 hyperglycemia cases and 585 normal glucose tolerance controls. Using polymerase chain reaction based restriction fragment length polymorphism (PCR-RFLP) method,we genotyped Pro12Ala polymorphism in PPAR3,2 gene. Resuits There is no significant difference in PPAR3,2 gene Pro12Ala polymorphism genotype frequencies distribution between case and control. In case group, Ala12 allele was associated with larger waist (P = 0.028 ) and lower serum insulin after oral administration glucose 0.5,1,2 hour (P = 0. 026 ; P = 0.040 ; P =0.038 ;respectively). Conclusions The results of our study suggest that Ala12 allele of PPAR3,2 gene could aggravate abdominal obesity and inhibit insulin secretion after glucose stimuli in hyperglycemia patients.
出处 《临床内科杂志》 CAS 2008年第2期102-105,共4页 Journal of Clinical Internal Medicine
基金 首都医学发展基金资助项目(2002-1017)
关键词 糖尿病 胰岛素 肥胖 过氧化物酶体增殖物激活受体γ2 多态性 Diabetes Insulin Obesity Peroxisome-proliferator-activated receptor gamma-2 Polymorphism
  • 相关文献

参考文献3

二级参考文献56

  • 1Toruner E Akbay E, Cakir N, Sancak B, Elbeg S, Taneri E Akturk Met al.Effects of PPARy and PPARct agonists on serum leptin levels in diet-induced obese rats. Horm Metab Res 2004, 36:226-230.
  • 2Jia DM, Otsuki M. Troglitazone stimulates pancreatic growth in normal rats.Pancreas 2002, 24:303-312.
  • 3Harmon JS, Gleason CE, Tanaka Y, Oseid EA, Hunter-Berger KK, Robertson RP. In vivo prevention of hyperglycemia also prevents glucotoxic effects on PDX-1 and insulin gene expression. Diabetes 1999, 48:1995-2000.
  • 4Schuit FC, Huypens P, Heimberg H, Pipeleers DG. Glucose sensing in pancreatic beta-cells: A model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes 2001, 50:1-11.
  • 5Cuesta-Munoz AL, Huopio H, Otonkoski T, Gomez-Zumaquero JM, Nanto-Salonen K, Rahier J, Lopez-Enriquez Set al. Severe persistent hyperinsulinemic hypoglycemia due to a de novo glucokinase mutation. Diabetes 2004, 53:2164-2168.
  • 6Thorens B, Guillam MT, Beermann F, Burcelin R, Jaquet M. Transgenic reexpression of GLUT 1 or GLUT2 in pancreatic beta cells rescues GLUT2-null mice from early death and restores normal glucose-stimulated insulin secretion. J Biol Chem 2000, 275:23751-23758.
  • 7Garvey WT. Glucose transport and NIDDM. Diabetes Care 1992, 15: 396-417.
  • 8Bonny C, Thompson N, Nicod P, Waeber G. Pancreatic-specific expression of the glucose transporter type 2 gene: Identification of cis-elements and islet-specific trans-acting factors. Mol Endocrinol 1995, 9:1413-1426.
  • 9Guillam MT, Dupraz P, Thorens B. Glucose uptake, utilization, and signaling in GLUT2-null islets. Diabetes 2000, 49:1485-1491.
  • 10Leibiger B, Leibiger IB, Moede T, Kemper S, Kulkarni RN, Kahn CR, de Vargas LM et al. Selective insulin signaling through A and B insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic betacells. Mol Cell 2001, 7:559-570.

共引文献27

同被引文献90

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部